Covered recipient · General Payments record
KATHERINE GAGAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$777.34
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $563.50 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $245.61 | 16 |
| Acerta Pharma LLC | $126.51 | 5 |
| Novo Nordisk AS | $49.07 | 2 |
| Lilly USA, LLC | $24.67 | 1 |
| Insulet Corporation | $23.29 | 1 |
| SANOFI-AVENTIS U.S. LLC | $20.84 | 1 |
| PFIZER INC. | $20.83 | 1 |
| Gilead Sciences, Inc. | $19.46 | 1 |
| Exact Sciences Corporation | $19.37 | 1 |
| DEXCOM, INC. | $13.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.25 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764046 | CMS |
| ABBVIE INC. | $18.82 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764048 | CMS |
| ABBVIE INC. | $12.68 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764050 | CMS |
| ABBVIE INC. | $32.89 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764052 | CMS |
| ABBVIE INC. | $4.03 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764054 | CMS |
| ABBVIE INC. | $7.06 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764056 | CMS |
| ABBVIE INC. | $4.90 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764058 | CMS |
| ABBVIE INC. | $26.23 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764060 | CMS |
| ABBVIE INC. | $25.58 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764062 | CMS |
| ABBVIE INC. | $9.76 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764064 | CMS |
| ABBVIE INC. | $29.44 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764066 | CMS |
| ABBVIE INC. | $6.68 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764068 | CMS |
| ABBVIE INC. | $14.57 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764070 | CMS |
| ABBVIE INC. | $15.67 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764072 | CMS |
| ABBVIE INC. | $17.50 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764074 | CMS |
| ABBVIE INC. | $16.55 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764076 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.42 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104770274 | CMS |
| AstraZeneca Pharmaceuticals LP | $65.21 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104678323 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.16 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105635458 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.34 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105543215 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.38 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105761938 | CMS |
| Dexcom, Inc. | $13.85 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153313123 | CMS |
| Exact Sciences Corporation | $19.37 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114665670 | CMS |
| Gilead Sciences, Inc. | $19.46 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133738176 | CMS |
| Insulet Corporation | $23.29 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804212 | CMS |
| Lilly USA, LLC | $24.67 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135121963 | CMS |
| Novo Nordisk Inc | $19.26 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097456023 | CMS |
| Novo Nordisk Inc | $29.81 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097409252 | CMS |
| PFIZER INC. | $20.83 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131487120 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.84 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139771788 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.